References
- Hooper, D. C. Biochim. Biophys. Acta 1998, 1400, 45-61. https://doi.org/10.1016/S0167-4781(98)00127-4
- Mascellino, M. T.; Farinelli, S.; Iegri, F.; Iona, E.; De Simone, C.Drugs Expert. Clin. Res. 1998, 24, 139-151.
- Kampranis, S. C.; Maxwell, A. J. Biol. Chem. 1998, 273(35),22615-22626. https://doi.org/10.1074/jbc.273.35.22615
- Hooper, D. C. Drug Resist Updates 1999, 2, 38-55. https://doi.org/10.1054/drup.1998.0068
- Drlica, K.; Zhao X. Microbiol Mol. Biol. Rev. 1997, 61, 377-392.
- Jazayeri, S.; Moshafi, M. H.; Firoozpour, L.; Emami, S.; Rajabalian,S.; Haddad, M.; Pahlavanzadeh, F.; Esnaashari, M.; Shafiee,A.; Foroumadi, A. European Journal of Medicinal Chemistry2009, 44, 1205-1209. https://doi.org/10.1016/j.ejmech.2008.09.012
- Foroumadi, A.; Emami, S.; Mehni, M.; Moshafi, M. H.; Shafiee, A.Bioorganic & Medicinal Chemistry Letters 2005, 15, 4536-4539. https://doi.org/10.1016/j.bmcl.2005.07.005
- Chen, Y. L.; Fang, K. C.; Sheu, J. Y.; Hsu, S. L.; Tzeng, C. C. J. Med. Chem. 2001, 44, 2374-2377. https://doi.org/10.1021/jm0100335
- Fang, K. C.; Chen, Y. L.; Sheu, J. Y.; Wang, T. C.; Tzeng, C. C.J. Med. Chem. 2000, 43, 3809-3812. https://doi.org/10.1021/jm000153x
- Foroumadi, A.; Mansouri, S.; Kiani, Z.; Rahmani, A. Eur. J. Med.Chem. 2003, 38, 851-854. https://doi.org/10.1016/S0223-5234(03)00148-X
- Ma, X.; Zhou, W.; Brun, R. Bioorganic & Medicinal Chemistry Letters 2009, 19(3), 986-989. https://doi.org/10.1016/j.bmcl.2008.11.078
- Sultana, N.; Arayne, M. S.; Rizvi, S. B. S.; Mesaik, M. A. Bull. Korean Chem. Soc. 2009, 30(10), 2294-2298. https://doi.org/10.5012/bkcs.2009.30.10.2294
- Arayne, M. S.; Sultana, N.; Haroon, U.; Mesaik, M. A.; Asif, M. Arch. Pharm. Res. 2009, 32(7), 967-974. https://doi.org/10.1007/s12272-009-1700-5
- Bauer, A. W.; Kirby, W. M. M.; Sherris, J. C.; Turck, M. Am. J. Clin. Pathol. 1966, 45, 493-496.
- Ozdek, S. C.; Miller, D.; Flynn, P. M.; Flynn, H. W., Jr. Ocular Infections 2006, 14(6), 347-351.
Cited by
- ChemInform Abstract: Synthesis, Characterization and Biological Evaluations of Ciprofloxacin Carboxamide Analogues. vol.42, pp.25, 2011, https://doi.org/10.1002/chin.201125154
- Novel derivatives of 5-amino-1-cyclopropyl-7-[(3R,5S)3,5-dimethylpiperazine-1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid: their synthesis, antimicrobial, antifungal, and urease inhibitory studies vol.23, pp.3, 2014, https://doi.org/10.1007/s00044-013-0699-9
- 4-Quinolone Derivatives and Their Activities Against Gram-negative Pathogens vol.55, pp.9, 2018, https://doi.org/10.1002/jhet.3244
- Novel Ciprofloxacin Derivatives for Polymer-Based Drug Delivery Systems vol.762, pp.1662-9795, 2018, https://doi.org/10.4028/www.scientific.net/KEM.762.36
- Total Syntheses of Lobaric Acid and Its Derivatives from the Antarctic Lichen Stereocaulon alpinum vol.81, pp.6, 2018, https://doi.org/10.1021/acs.jnatprod.8b00227
- Fluoroquinolone-3-carboxamide Amino Acid Conjugates: Synthesis, Antibacterial Properties And Molecular Modeling Studies vol.15, pp.None, 2019, https://doi.org/10.2174/1573406415666190904143852
- Theoretical molecular predictions and antimicrobial activities of newly synthesized molecular hybrids of norfloxacin and ciprofloxacin vol.57, pp.1, 2011, https://doi.org/10.1002/jhet.3768